A new electronic implant system can help lab-grown pancreatic cells mature and function properly, potentially providing a ...
News Medical on MSN
Researchers develop new score to predict the risk of liver cancer
Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a score that predicts the risk of liver cancer. Published in the scientific journal ...
A multinational, multidisciplinary group of experts has created a consensus document to guide diagnosis, staging and management of adults with alpha-1 antitrypsin deficiency-associated liver disease, ...
The FDA has approved Optune Pax for the treatment of adult patients with locally advanced pancreatic cancer alongside gemcitabine and nab-paclitaxel.
Researchers are exploring the various cancer risks or protections tied with sodium-glucose cotransporter-2 inhibitors (SGLT2i) vs glucagon-like peptide-1 receptor agonists (GLP-1 RA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results